Bolaget minskar både omsättning och rörelseresultat under kvartalet men rapporten bjuder på några lj...
Redeye comments on Coala Life’s Q2’22 report and the acquisition of Vitrics.
10% organisk tillväxt Intäkter i Q2'22 uppgick till 192,5 mkr (171,5 mkr i Q2'21), vilket motsvarar ...
Q2-rapport OncoZenge presenterade under gårdagen sin rapport för det andra kvartalet.
Utvecklingen har varit stabil i samtliga regioner och fokus ligger på att återfå tidigare momentum o...
19% revenue growth y-o-y, gross profit 21% above Reiterates 2022 target, but sees increased uncertai...
Decent NWT ramp-up in Q2, will accelerate in H2 Continued NWC build-up could cause some fears 13-8x ...
Redeye comments on Adverty’s Q2’22 report. Both sales and profitability came in below our expectatio...
Reassuring Q2 numbers and outlook We raise ‘23e-‘24e estimates Share is trading at 6x ’23e EV/EBITA ...
Adj. EBIT SEK 10.4m (+38% vs. ABGSCe 7.5m) Isolated Q2 figures imply 7-4% estimate upgrades 22x ’22e...
Raketech just released a somewhat soft Q2 report, and a decent start to Q3.
Marimekko delivered strong Q2 result, with net sales broadly in line with and EBIT beating our estim...
Conducting business in Russia becoming more difficult Evaluating a potential divestment 2-7x ’22e-’2...
Redeye lowers its forecast and base case valuation of Alelion following a Q2’22 report on the weak s...
Rapporten kommer in enligt förväntan och Plejd fortsätter växa under lönsamhet.
Will close down its groundwood pulp line at year-end Invests SEK 160-200m into a new CTMP line CTMP ...
As expected, Q2 was a softer quarter High activity level expected in H2’22 P/NAV of 0.
Redeye considers Alelion’s Q2’22 report on the weak side as some orders were pushed into the future,...
Netum had provided preliminary figures before the H1 results and the earnings report held no surpris...
TCECUR har publicerat bolagets delårsrapport för andra kvartalet 2022, där det står klart att koncer...
